<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Decentralised Clinical Trials &#8211; Karkinos Healthcare</title>
	<atom:link href="https://www.karkinos.in/category/digital-oncology/decentralised-clinical-trials/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.karkinos.in</link>
	<description>A technology-led, purpose driven oncology platform, enabling discovery through delivery of care</description>
	<lastBuildDate>Tue, 21 Nov 2023 06:22:05 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.karkinos.in/wp-content/uploads/2021/03/Transparent-Favicon.png</url>
	<title>Decentralised Clinical Trials &#8211; Karkinos Healthcare</title>
	<link>https://www.karkinos.in</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Ushering the era of Decentralised Oncology Clinical Trials in India</title>
		<link>https://www.karkinos.in/k-vani/ushering-the-era-of-decentralised-oncology-clinical-trials-in-india-2/</link>
		
		<dc:creator><![CDATA[Anusha Ashwin]]></dc:creator>
		<pubDate>Tue, 21 Nov 2023 06:21:01 +0000</pubDate>
				<category><![CDATA[Decentralised Clinical Trials]]></category>
		<category><![CDATA[Digital Oncology]]></category>
		<category><![CDATA[cancers]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[patient]]></category>
		<guid isPermaLink="false">https://www.karkinos.in/?p=24693</guid>

					<description><![CDATA[This article brings to fore the expertise of Karkinos Healthcare in providing Decentralised Clinical Trials (DCTs) services in bringing about novel approaches to cancer treatment. To know more about the compelling reasons for the emergence of DCTs in India and what makes the country a hotbed for global pharmaceutical companies to conduct DCTs, please subscribe to the full article at https://karkinos.in/clinicaltrials/.
]]></description>
		
		
		
			</item>
	</channel>
</rss>
